CEL-SCI Corp. (CVM) Posts Wide Loss on Strong Revs
Tweet
Share
E-mailGet Alerts CVM Hot Sheet
Price: $1.11 +14.43%
Financial Fact:
NET (LOSS) INCOME: -3.85M
Today's EPS Names:
CGEH, NAKA, APOG, More
Financial Fact:
NET (LOSS) INCOME: -3.85M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
CEL-SCI Corp. (NYSE: CVM) reported Q2 loss of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $43.82 million versus the consensus estimate of $30 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CEL-SCI signs distribution deal with Saudi Amarox for cancer drug
- CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
- H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
